Product Security

The cybersecurity landscape is continually evolving, and iVEAcare continuously assesses new vulnerabilities that could impact the safety, effectiveness, or intended use of our neuromodulation products.

Questions or concerns about product security?

Patient question contact: +1 (651) 728-4832 or your physician.

Security question email: info@iveacare.com

Coordinated Vulnerability Disclosure Process

If you believe you have identified a potential security vulnerability in our products, please follow the coordinated disclosure process below:

Email: info@iveacare.com

Provide your contact name, email address, and phone number. Include a technical description of the issue or vulnerability, the devices it impacts, and any additional relevant information.

Vulnerability Investigation

We will investigate the potential vulnerability. We will conduct a risk analysis to determine appropriate action and provide a summary of our findings.

Once new vulnerabilities are evaluated, iVEAcare, as required for incident response, may need to notify regulatory authorities which may include the FDA, international regulatory agencies (such as the TGA), or the Cybersecurity and Infrastructure Security Agency (CISA). These agencies may provide support and input into incident response and the dissemination of information.

Security Bulletins

iVEAcare may disseminate product security updates and notifications via our website.

Last Updated: March 17, 2026